Silo Pharma, Inc.
SILO
$0.63
-$0.011-1.72%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -28.65% | -54.35% | -40.68% | 8.02% | 11.55% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1,350.00% | -100.00% | -100.00% | -97.03% | -100.53% |
| Change in Net Operating Assets | -1,577.69% | 461.79% | 4.43% | -52.61% | -120.61% |
| Cash from Operations | -95.69% | -0.81% | -25.63% | -33.05% | -21.00% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 792.83% | -100.85% | -103.21% | 124.94% | 101.62% |
| Cash from Investing | 792.83% | -100.85% | -103.21% | 124.94% | 101.62% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | 100.00% | 100.00% | 55.95% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 100.00% | 1,295.26% | 1,333.28% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 10.18% | -128.73% | 764.88% | 140.78% | 87.23% |